Charts Sigyn Therapeutics, Inc.

Stocks

Market Closed - OTC Markets 14:29:43 2026-05-27 EDT			5-day change	1st Jan Change
0.0316 ^USD	-18.97%		-9.71%	-98.15%

05-07	Oragenics signs letter of intent to license Cardiodialysis(TM) technology from Sigyn Therapeutics to target TBI-induced systemic inflammation	RE
05-07	Oragenics Signs Letter of Intent to License CardioDialysis? Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation	CI

ProRealTime Chart